| Detected | Trial | Change |
|---|---|---|
| 2026-05-29 | NCT07335601 Study to Evaluate Resmetirom in Post-Liver Transplant Patients With MASH |
date change Primary completion pushed: 2027-07 -> 2028-08 |
| 2026-05-29 | NCT07335601 Study to Evaluate Resmetirom in Post-Liver Transplant Patients With MASH |
date change Completion pushed: 2027-12 -> 2029-03 |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT04951219 | A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients… | Non-Alcoholic Fatty Liver Disease | Active, Not Recruiting |
| NCT03900429 | A Phase 3 Study to Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients… | NASH - Nonalcoholic Steatohepatitis | Active, Not Recruiting |
| NCT05500222 | A Phase 3 Study to Evaluate the Effect of Resmetirom on Clinical Outcomes in Patients… | NASH | Active, Not Recruiting |
| Phase 2 | |||
| NCT07143968 | A Study to Evaluate the Use of Resmetirom in Participants With MASLD and HIV | MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease | Recruiting |
| NCT07335601 | Study to Evaluate Resmetirom in Post-Liver Transplant Patients With MASH | MASH - Metabolic Dysfunction-Associated Steatohepatitis | Recruiting |